FSB Premier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390K Buy
+6,438
New +$375K 0.12% 160
2022
Q1
Sell
-2,655
Closed -$165K 176
2021
Q4
$165K Buy
+2,655
New +$156K 0.07% 137

Other funds holding BMY

FSB Premier Wealth Management's BMY Position: Q1 2026 in Review

FSB Premier Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 6,438 shares worth $390K. The stake represents 0.12% of the portfolio and ranks #160 among its holdings. This is a return to the name: FSB Premier Wealth Management previously reported a position in BMY as recently as Q4 2021.

FSB Premier Wealth Management first reported a position in BMY in Q4 2021 and has held it in 2 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • FSB Premier Wealth Management held 6,438 shares of Bristol-Myers Squibb worth $390K as of Q1 2026.
  • Bristol-Myers Squibb was a new FSB Premier Wealth Management position in Q1 2026.
  • Bristol-Myers Squibb made up 0.12% of FSB Premier Wealth Management's portfolio in Q1 2026, its #160 holding.
  • FSB Premier Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 2 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.